UK hails blood pressure findings
TAKING repeated blood pressure readings over a 24-hour period rather than a one-off measurement in the clinic is the most cost-effective way of deciding who should be prescribed drugs for hypertension, according to a study published yesterday.
The findings in favor of so-called ambulatory blood pressure monitoring were immediately adopted by the UK's health costs watchdog, the National Institute for Health and Clinical Excellence, in new guidelines on how to diagnose and when to treat high blood pressure.
Bryan Williams, a professor of medicine at Leicester University and chairman of the NICE guideline development group, said the change would affect the treatment of millions of people and was "a step-change likely to be replicated across the world."
Richard McManus, of Birmingham University, who led the study published in The Lancet medical journal which prompted the guideline change, said: "Ambulatory monitoring allows better targeting of blood pressure treatment. It is cost-saving in the long term as well as more effective."
About 1 billion people worldwide have high blood pressure, a major risk factor in cardiovascular disease.
The findings in favor of so-called ambulatory blood pressure monitoring were immediately adopted by the UK's health costs watchdog, the National Institute for Health and Clinical Excellence, in new guidelines on how to diagnose and when to treat high blood pressure.
Bryan Williams, a professor of medicine at Leicester University and chairman of the NICE guideline development group, said the change would affect the treatment of millions of people and was "a step-change likely to be replicated across the world."
Richard McManus, of Birmingham University, who led the study published in The Lancet medical journal which prompted the guideline change, said: "Ambulatory monitoring allows better targeting of blood pressure treatment. It is cost-saving in the long term as well as more effective."
About 1 billion people worldwide have high blood pressure, a major risk factor in cardiovascular disease.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔$粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.